Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT06702995 · RECRUITING
Trial details
- NCT number
- NCT06702995
- Sponsor
- Evopoint Biosciences Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-19
- Primary completion
- 2026-05-13
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.